Artificial intelligence is transforming enzyme engineering by enabling researchers to explore protein sequence space more efficiently and prioritize promising variants before laboratory testing. Instead of relying exclusively on large-scale screening campaigns, AI-guided enzyme design helps focus experimental resources on variants with the highest predicted potential.
Neoncorte Bio combines artificial intelligence, machine learning, computational biology, and protein language models to support the design and optimization of industrial enzymes, therapeutic enzymes, and biocatalysts.
Our AI-assisted workflows complement laboratory experimentation and accelerate iterative Design-Build-Test-Learn (DBTL) cycles.
AI enzyme design applies computational models to predict how amino acid substitutions may influence enzyme performance. By integrating sequence analysis, structural information, and experimental data, machine learning models help researchers identify mutations that are more likely to achieve engineering objectives.